Bolt Biotherapeutics Inc.
BOLT | NASDAQ
$3.59
+$0.03 (+0.84%)
At close: Sep 21, 2026, 4:00 PM ET
$3.59
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:10 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.31 | -6.48 | -12.24 | -11.30 | -35.13 | -323.12 |
PEG Ratio | 0 | 0.66 | 0.60 | 0.64 | -0.87 | 6.88 |
PS Ratio | 1.33 | 2.66 | 5.38 | 8.48 | 145.44 | 5.04K |
PB Ratio | 0.39 | 0.36 | 0.38 | 0.28 | 0.73 | -11.10 |
P/FCF Ratio | -0.26 | -0.33 | -0.61 | -0.62 | -3.08 | -23.04 |
P/OCF Ratio | -0.26 | -0.33 | -0.61 | -0.63 | -3.21 | -24.63 |
OCF/S Ratio | -517.87 | -797 | -882.75 | -1.34K | -4.53K | -20.48K |
Debt / Equity Ratio | 0.87 | 0.44 | 0.18 | 0.13 | 0.10 | -0.10 |
Quick Ratio | 3.59 | 3.20 | 5.17 | 7.47 | 8.87 | 2.25 |
Current Ratio | 3.59 | 3.20 | 5.17 | 7.47 | 8.87 | 2.25 |
Asset Turnover | 0.14 | 0.08 | 0.05 | 0.03 | 0 | 0 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -125.92% | -110.35% | -61.38% | -51.37% | -39.42% | 57.87% |
Return on Assets | -58.81% | -63.35% | -43.31% | -38.67% | -32.04% | -130.48% |
Return on Invested Capital | -67.72% | -84.91% | -53.62% | -43.62% | -32.12% | -133.72% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 80.62% | 100% | -681.39% | -1.18K% | -5.9K% | -17.37K% |
Net Profit Margin | -433.74% | -820.78% | -878.58% | -1.54K% | -7.82K% | -26.29K% |
Pretax Profit Margin | -433.74% | -820.78% | -878.58% | -1.54K% | -7.82K% | -26.29K% |
Operating Profit Margin | -450.07% | -949.91% | -967.45% | -1.58K% | -7.36K% | -21.29K% |
FCF Margin | -518.80% | -797.53% | -885.36% | -1.37K% | -4.71K% | -21.89K% |
EBITDA Margin | -414.36% | -864.17% | -855.04% | -1.51K% | -7.73K% | -21.03K% |
Add to Watchlist
Select watchlists to add or remove BOLT